戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 et of hypoxia-inducible factor 1 (Hif-1) and peroxisome proliferator-activated receptors.
2  to a putatively advantageous allele for the peroxisome proliferator-activated receptor A (PPARA) gen
3                           Bezafibrate, a pan-peroxisome proliferator-activated receptor agonist, has
4 pression was enhanced by insulin-sensitizing peroxisome proliferator-activated receptor agonists and
5 1) in aged Paneth cells inhibits activity of peroxisome proliferator activated receptor alpha (PPAR-a
6 e glutathione-S-transferase 4-4 (Gsta4(-/-))/peroxisome proliferator activated receptor alpha (Ppara(
7 esponsive element binding protein 1 (CREB1), peroxisome proliferator activated receptor alpha (PPARA)
8 receptor type 1 (CB1) or type 2 (CB2) or via peroxisome proliferator-activated receptor alpha (PPAR-a
9  adipocytes by controlling the expression of peroxisome proliferator-activated receptor alpha (Ppara)
10 iptome analysis identifies the lipid-sensing peroxisome proliferator-activated receptor alpha (PPARal
11 arnitine palmitoyltransferase 1A (CPT1A) and peroxisome proliferator-activated receptor alpha (PPARal
12 arvation, CREBH regulates and interacts with peroxisome proliferator-activated receptor alpha (PPARal
13                                              Peroxisome proliferator-activated receptor alpha (PPARal
14 n, Acot1 knockdown reduced the expression of peroxisome proliferator-activated receptor alpha (PPARal
15                                              Peroxisome proliferator-activated receptor alpha (PPARal
16 hepatic AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptor alpha (PPARal
17  and stabilizes the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARal
18                         CREBH interacts with peroxisome proliferator-activated receptor alpha (PPARal
19 igated whether Astragaloside IV can activate peroxisome proliferator-activated receptor alpha (PPARal
20 such as bezafibrate, known activators of the peroxisome proliferator-activated receptor alpha (PPARal
21 ific DRE that overlaps binding sequences for peroxisome proliferator-activated receptor alpha (PPARal
22 or the nuclear receptor transcription factor peroxisome proliferator-activated receptor alpha (PPARal
23  activation of transcription factors such as peroxisome proliferator-activated receptor alpha (PPARal
24 sed expression were known to be regulated by peroxisome proliferator-activated receptor alpha (PPARal
25  fasting, activation of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARal
26 dy was to investigate the protective role of peroxisome proliferator-activated receptor alpha (PPARal
27                                              Peroxisome proliferator-activated receptor alpha (PPARal
28      PFAAs can activate transcription factor peroxisome proliferator-activated receptor alpha (PPARal
29 ansforming growth factor beta (TGF-beta) and peroxisome proliferator-activated receptor alpha (PPARal
30 ation, due to a reduced abundance of mRNA of peroxisome proliferator-activated receptor alpha (PPARal
31                               Fenofibrate, a peroxisome proliferator-activated receptor alpha (PPARal
32 (TGF-beta)-regulated phospho-Akt (p-Akt) and peroxisome proliferator-activated receptor alpha (PPARal
33 ecular analysis unraveled that inhibition of peroxisome proliferator-activated receptor alpha activit
34 ardiac lipotoxicity, and discuss the role of peroxisome proliferator-activated receptor alpha and dys
35 ated by several nuclear receptors, including peroxisome proliferator-activated receptor alpha and/or
36 omatin immunoprecipitation assays identified peroxisome proliferator-activated receptor alpha as a me
37 nvolved in fatty acid beta-oxidation through peroxisome proliferator-activated receptor alpha phospho
38  gene is an AMP-activated protein kinase and peroxisome proliferator-activated receptor alpha respons
39 Falpha (3.0-fold), whereas the expression of peroxisome proliferator-activated receptor alpha target
40                                              Peroxisome proliferator-activated receptor alpha target
41 anscription factors, particularly PPARalpha (peroxisome proliferator-activated receptor alpha), and l
42 to the increased transcriptional activity of peroxisome proliferator-activated receptor alpha, the tr
43 ment binding protein-hepatocyte specific and peroxisome proliferator-activated receptor alpha, which
44 (S)-HDHA as a possible endogenous ligand for peroxisome proliferator-activated receptor alpha.
45 a-oxidation: fibroblast growth factor 21 and peroxisome proliferator-activated receptor alpha.
46  for the farnesoid X receptor (FXR) and dual peroxisome proliferator-activated receptor alpha/delta (
47                           Dual activation of peroxisome proliferator-activated receptors alpha and de
48 cumulation in the intestine and up-regulates peroxisome proliferator-activated receptors alpha and ga
49 s study was to determine whether downstream [peroxisome proliferator-activated-receptor alpha (PPARal
50 ect of PERC on bodyweight loss, induction of peroxisome proliferator activated receptor-alpha (PPARal
51 (FoxO), AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptor-alpha (PPAR-a
52 palmitoylethanolamide (PEA), a lipid-derived peroxisome proliferator-activated receptor-alpha (PPAR-a
53 receptor-y coactivator 1-alpha (PGC-1alpha), peroxisome proliferator-activated receptor-alpha (PPARal
54 EA-m could be correlated at least in part to peroxisome proliferator-activated receptor-alpha activat
55 sepsis and to identify the mechanism whereby peroxisome proliferator-activated receptor-alpha confers
56        We sought to characterize the role of peroxisome proliferator-activated receptor-alpha in seps
57                                              Peroxisome proliferator-activated receptor-alpha is sign
58 gulation of nhr-49 (an ortholog of the human peroxisome proliferator-activated receptor-alpha), and a
59           These results suggest that altered peroxisome proliferator-activated receptor-alpha-mediate
60 uction of nitrate to NO and independently of peroxisome proliferator-activated receptor-alpha.
61 ation of the estrogen, aryl hydrocarbon, and peroxisome proliferator-activated receptors; and oxidati
62                                              Peroxisome proliferator activated receptor beta/delta (P
63 or-activated receptor-alpha (PPARalpha), and peroxisome proliferator-activated receptor beta/delta (P
64 h TGFbeta1 for receptor binding, while PPAR (peroxisome proliferator-activated receptor)-beta/delta a
65    CD36 fine-tuned mitochondrial fitness via peroxisome proliferator-activated receptor-beta signalin
66                                      Because peroxisome proliferator-activated receptor-beta/delta (P
67                Nuclear receptor co-activator peroxisome proliferator-activated receptor co-activator
68                                We found that peroxisome proliferator-activated receptor delta (PPAR-d
69      Mechanistically, a HFD induces a robust peroxisome proliferator-activated receptor delta (PPAR-d
70                                          The peroxisome proliferator-activated receptor delta (PPARD)
71                 The nuclear hormone receptor peroxisome proliferator-activated receptor delta (PPARde
72                                              Peroxisome proliferator-activated receptor delta (PPARde
73                                              Peroxisome proliferator-activated receptor delta (PPARde
74 Moreover, FAs from higher lipolysis activate peroxisome proliferator-activated receptor delta to indu
75 elpar is a potent, selective agonist for the peroxisome proliferator-activated receptor-delta (PPAR-d
76  growth hormone secretagogue ibutamoren, the peroxisome proliferator-activated receptor-delta agonist
77 ed attenuation of phagocytosis-induced PPAR (peroxisome proliferator-activated receptor) expression.
78                      Activation of the PPAR (peroxisome proliferator-activated receptor)-fatty acid o
79 f human chorionic gonadotropin (hCGbeta) and peroxisome proliferator activated receptor gamma (PPARga
80  chain amino acids (BCAA), and regulation of peroxisome proliferator activated receptor gamma (PPARga
81 ty to activate the nuclear hormone receptor, peroxisome proliferator activated receptor gamma (PPARga
82                         The nuclear receptor peroxisome proliferator activated receptor gamma (PPARga
83 TZDs) target the transcriptional activity of peroxisome proliferator activated receptor gamma (PPARga
84                                              Peroxisome proliferator activated receptor gamma coactiv
85 e dismutase, mitochondrial KATP channels and peroxisome proliferator activated receptor gamma coactiv
86                                              Peroxisome proliferator activated receptor gamma, coacti
87 with markedly diminished ability to activate peroxisome proliferator-activated receptor gamma (MSDC-0
88   We studied interactions between polar bear peroxisome proliferator-activated receptor gamma (pbPPAR
89                Pharmacological activation of peroxisome proliferator-activated receptor gamma (PPAR-g
90                                              Peroxisome proliferator-activated receptor gamma (PPAR-g
91 ng through the intracellular butyrate sensor peroxisome proliferator-activated receptor gamma (PPAR-g
92 CL10 and IL-6 transcript levels, and induced peroxisome proliferator-activated receptor gamma (PPAR-g
93 action between OmpA and Ecgp96 downregulates peroxisome proliferator-activated receptor gamma (PPAR-g
94                                          The peroxisome proliferator-activated receptor gamma (PPAR-g
95  restored expression of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-g
96 homeostasis, epithelial hypoxia derived from peroxisome proliferator-activated receptor gamma (PPAR-g
97                                          The peroxisome proliferator-activated receptor gamma (PPAR-g
98 ified ETS translocation variant 4 (ETV4) and peroxisome proliferator-activated receptor gamma (PPARG)
99 on of several of its target genes, including peroxisome proliferator-activated receptor gamma (PPARG)
100 alus) and blue whale (Balaenoptera musculus) peroxisome proliferator-activated receptor gamma (PPARG)
101 een in a Pten-null background, we identified peroxisome proliferator-activated receptor gamma (Pparg)
102 he HFCF diet, WT mice displayed up-regulated peroxisome proliferator-activated receptor gamma (Pparg)
103                                              Peroxisome proliferator-activated receptor gamma (PPARga
104 hat binds and activates the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
105 d structures of nuclear receptors, including peroxisome proliferator-activated receptor gamma (PPARga
106  conformational ensemble of nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
107  to stimulate or inhibit the activity of the peroxisome proliferator-activated receptor gamma (PPARga
108                                              Peroxisome proliferator-activated receptor gamma (PPARga
109 pha), C/EBPbeta, C/EBPdelta, KLF5, KLF9, and peroxisome proliferator-activated receptor gamma (PPARga
110  their direct action on the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
111 ich was recruited to the promoter of Nox1, a peroxisome proliferator-activated receptor gamma (PPARga
112 iated macrophage differentiation by cleaving peroxisome proliferator-activated receptor gamma (PPARga
113 tion depends on interactions between Sp1 and peroxisome proliferator-activated receptor gamma (PPARga
114 y isoflavone genistein, a natural agonist of peroxisome proliferator-activated receptor gamma (PPARga
115  miR-503 expression is directly regulated by peroxisome proliferator-activated receptor gamma (PPARga
116 und that this defect is because of defective peroxisome proliferator-activated receptor gamma (PPARga
117                                              Peroxisome proliferator-activated receptor gamma (PPARga
118                                              Peroxisome proliferator-activated receptor gamma (PPARga
119                  We have recently shown that peroxisome proliferator-activated receptor gamma (PPARga
120        In contrast, the master adipogenic TF peroxisome proliferator-activated receptor gamma (PPARga
121                                              Peroxisome proliferator-activated receptor gamma (PPARga
122 ancer-binding protein alpha (C/EBPalpha) and peroxisome proliferator-activated receptor gamma (PPARga
123                         The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
124                   A class of small molecules-peroxisome proliferator-activated receptor gamma (PPARga
125                                              Peroxisome proliferator-activated receptor gamma (PPARga
126 d the extracellular matrix, particularly the peroxisome proliferator-activated receptor gamma (Pparga
127                                              Peroxisome Proliferator-Activated Receptor Gamma (PPARga
128 lipid droplet formation and the induction of peroxisome proliferator-activated receptor gamma (PPARga
129 gh levels of TNF and IL-12 but low levels of peroxisome proliferator-activated receptor gamma (PPARga
130 anoparticle (NP) platforms to deliver either Peroxisome Proliferator-Activated Receptor gamma (PPARga
131   We report direct activation of the nuclear peroxisome proliferator-activated receptor gamma (PPARga
132 ative DNA binding behavior of the adipogenic peroxisome proliferator-activated receptor gamma (PPARga
133          We report two crystal structures of peroxisome proliferator-activated receptor gamma (PPARga
134 n of master adipogenic transcription factors peroxisome proliferator-activated receptor gamma (PPARga
135                                              Peroxisome proliferator-activated receptor gamma (PPARga
136 duction of prostaglandin J2 (PGJ2) activates peroxisome proliferator-activated receptor gamma (PPARga
137 ere, we tested this hypothesis on three NRs: peroxisome proliferator-activated receptor gamma (PPARga
138 und 3a that possesses weak proadipogenic and peroxisome proliferator-activated receptor gamma (PPARga
139 ow GIP-R expression can be regulated through peroxisome proliferator-activated receptor gamma (PPARga
140 nd profiling of photoswitchable agonists for peroxisome proliferator-activated receptor gamma (PPARga
141 pid metabolism genes during NAFLD, including peroxisome proliferator-activated receptor gamma (PPARga
142 -depleted mice, and conditional OPC-specific peroxisome proliferator-activated receptor gamma (PPARga
143 /enhancer-binding protein family members and peroxisome proliferator-activated receptor gamma (PPARga
144 ot BCRP transport activity were blocked by a peroxisome proliferator-activated receptor gamma (PPARga
145                  The expression of placental peroxisome proliferator-activated receptor gamma (r = -0
146 ver development by suppressing expression of peroxisome proliferator-activated receptor gamma 2 and l
147      In LX-2 cells, FXR activation increased peroxisome proliferator-activated receptor gamma activit
148 ented the inflammatory response dependent on peroxisome proliferator-activated receptor gamma activit
149 N-terminal kinase inhibitor SP600125 and the peroxisome proliferator-activated receptor gamma agonist
150 , similar to TPHP, found that ciglitazone (a peroxisome proliferator-activated receptor gamma agonist
151 lated expression of the transcription factor peroxisome proliferator-activated receptor gamma and its
152 lta-prostaglandin J2-dependent activation of peroxisome proliferator-activated receptor gamma and mac
153 ated protein 2 expression and suppression of peroxisome proliferator-activated receptor gamma and p27
154                           Erk5 regulation of peroxisome proliferator-activated receptor gamma co-acti
155 s, including uncoupling protein 1 (Ucp1) and peroxisome proliferator-activated receptor gamma co-acti
156                                          The peroxisome proliferator-activated receptor gamma coactiv
157  mitochondrial biogenesis regulatory protein peroxisome proliferator-activated receptor gamma coactiv
158  voluntary wheel running and muscle-specific peroxisome proliferator-activated receptor gamma coactiv
159              The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactiv
160 khead box transcription factors O (Foxo) and Peroxisome proliferator-activated receptor gamma coactiv
161                                          The peroxisome proliferator-activated receptor gamma coactiv
162  mitochondrial biogenesis, in particular via peroxisome proliferator-activated receptor gamma coactiv
163 e key regulator of mitochondrial biogenesis, peroxisome proliferator-activated receptor gamma coactiv
164                     The expression levels of peroxisome proliferator-activated receptor gamma coactiv
165                                          The peroxisome proliferator-activated receptor gamma coactiv
166 triggers complex adaptive responses in which peroxisome proliferator-activated receptor gamma coactiv
167                      Caffeine also increased peroxisome proliferator-activated receptor gamma coactiv
168      This coincided with decreased levels of peroxisome proliferator-activated receptor gamma coactiv
169 ssion, potentially through the regulation of peroxisome proliferator-activated receptor gamma coactiv
170 gnature genes uncoupling protein (UCP)-1 and peroxisome proliferator-activated receptor gamma coactiv
171 ouse, these UCP1(+) cells also expressed the peroxisome proliferator-activated receptor gamma coactiv
172                                              Peroxisome proliferator-activated receptor gamma coactiv
173 uction and ATP levels, reduced expression of peroxisome proliferator-activated receptor gamma coactiv
174 nd ZR75.1 breast cancer cells, IGF-1 induces peroxisome proliferator-activated receptor gamma coactiv
175      Here we demonstrate, unexpectedly, that peroxisome proliferator-activated receptor gamma coactiv
176                                              Peroxisome proliferator-activated receptor gamma coactiv
177 but was independent of the activation of the peroxisome proliferator-activated receptor gamma coactiv
178 e Huh7, the coexpression of the coactivators peroxisome proliferator-activated receptor gamma coactiv
179 city are known to regulate and interact with peroxisome proliferator-activated receptor gamma coactiv
180     Here we demonstrate that the coactivator peroxisome proliferator-activated receptor gamma coactiv
181 tably, the mitochondrial DNA copy number and peroxisome proliferator-activated receptor gamma coactiv
182                The transcriptional regulator peroxisome proliferator-activated receptor gamma coactiv
183 ation) and increased promoter methylation of peroxisome proliferator-activated receptor gamma coactiv
184 evels and the expression of four isoforms of peroxisome proliferator-activated receptor gamma coactiv
185 chondrial transcription factor A (TFAM), and peroxisome proliferator-activated receptor gamma coactiv
186 idrug resistance-associated protein 2 and 4, peroxisome proliferator-activated receptor gamma coactiv
187 ated the role of ERK1/2 on the expression of peroxisome proliferator-activated receptor gamma coactiv
188  mitochondrial respiration between legs, but peroxisome proliferator-activated receptor gamma coactiv
189     A subset of melanomas display heightened peroxisome proliferator-activated receptor gamma coactiv
190 sis (uncoupling protein-1, deiodinase-2, and peroxisome proliferator-activated receptor gamma coactiv
191                Overexpression of coactivator peroxisome proliferator-activated receptor gamma coactiv
192 that fuses paired box gene 8 (PAX8) with the peroxisome proliferator-activated receptor gamma gene (P
193                                  The nuclear peroxisome proliferator-activated receptor gamma has wel
194 nase 2, 15-deoxy Delta-prostaglandin J2, and peroxisome proliferator-activated receptor gamma in this
195           Finally, application of a specific peroxisome proliferator-activated receptor gamma inhibit
196 BPD that is not dependent on the decrease in peroxisome proliferator-activated receptor gamma levels.
197 or kappaB and NOS2, and an inhibition of the peroxisome proliferator-activated receptor gamma network
198  c-Jun N-terminal kinase, thereby inhibiting peroxisome proliferator-activated receptor gamma through
199         Notably, I148M cells display reduced peroxisome proliferator-activated receptor gamma transcr
200 on of the glucose/lipid metabolism regulator peroxisome proliferator-activated receptor gamma was ass
201 m with 5-amino salicylic acid, a PPAR-gamma (peroxisome proliferator-activated receptor gamma) agonis
202 downstream transcription factors, PPARgamma (peroxisome proliferator-activated receptor gamma), and p
203 ammalian target of rapamycin or reactivating peroxisome proliferator-activated receptor gamma, an LAL
204 ing STAT3, STAT6, Kruppel-like factor 4, and peroxisome proliferator-activated receptor gamma, and ca
205 o the endoplasmic reticulum, down-regulating peroxisome proliferator-activated receptor gamma, and re
206 he mitochondrial transcriptional coactivator peroxisome proliferator-activated receptor gamma, coacti
207 nd import of the transcriptional coactivator peroxisome proliferator-activated receptor gamma-coactiv
208 e injections in rats were reported to induce peroxisome proliferator-activated receptor gamma-depende
209 gulating macrophage lipid metabolism through peroxisome proliferator-activated receptor gamma-depende
210 fects thought to be due to activation of the peroxisome proliferator-activated receptor gamma.
211  adipogenic differentiation was mediated via peroxisome proliferator-activated receptor gamma.
212 lta-prostaglandin J2-dependent activation of peroxisome proliferator-activated receptor gamma.
213 macologic inhibitors of cyclooxygenase 2 and peroxisome proliferator-activated receptor gamma.
214  downregulating Ucp1 and Pgc1alpha genes via peroxisome proliferator-activated receptor gamma.
215  phosphatases, and ameliorated activation of peroxisome proliferator-activated receptor gamma/sterol
216 ificant alterations in pathways regulated by peroxisome proliferator activated receptor-gamma (PPARga
217 through suppression of hepatic expression of peroxisome proliferator activated receptor-gamma and gen
218 wk with rosiglitazone, a specific agonist of peroxisome proliferator-activated receptor-gamma (PPAR-g
219 the upregulation of the transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-g
220           Exogenous AC caused an increase in peroxisome proliferator-activated receptor-gamma (PPAR-g
221 d patients with NAFLD, hepatic expression of peroxisome proliferator-activated receptor-gamma (PPARG)
222             Evidence suggests that targeting Peroxisome Proliferator-Activated Receptor-gamma (PPARga
223  X receptors alpha and beta (LXRalpha,beta), peroxisome proliferator-activated receptor-gamma (PPARga
224 13.1 treatment were associated with enhanced peroxisome proliferator-activated receptor-gamma (PPARga
225                                              Peroxisome proliferator-activated receptor-gamma (PPARga
226  but improvement of insulin resistance using peroxisome proliferator-activated receptor-gamma (PPARga
227 al interactions between prenatal DHA and the peroxisome proliferator-activated receptor-gamma (PPARga
228 or (ER)-, glucocorticoid receptor (GR)-, and peroxisome proliferator-activated receptor-gamma (PPARga
229                                              Peroxisome proliferator-activated receptor-gamma (PPARga
230                                              Peroxisome proliferator-activated receptor-gamma (PPARga
231                             Nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARga
232 (TZD) antidiabetic drugs, which activate the peroxisome proliferator-activated receptor-gamma (PPARga
233 ented and even partially reversed ex vivo by peroxisome proliferator-activated receptor-gamma agonist
234                    Furthermore, we show that peroxisome proliferator-activated receptor-gamma agonist
235  a healthy human (mini-)organ, and show that peroxisome proliferator-activated receptor-gamma agonist
236                                              Peroxisome proliferator-activated receptor-gamma agonist
237                In addition, the up-regulated peroxisome proliferator-activated receptor-gamma and -al
238  on the transcription coactivator PGC-1beta (peroxisome proliferator-activated receptor-gamma co-acti
239 ion of mitochondrial biogenesis (PGC-1alpha [peroxisome proliferator-activated receptor-gamma coactiv
240  mediated by the transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactiv
241 cal exercise and thyroid hormone mediate the peroxisome proliferator-activated receptor-gamma coactiv
242       Thyroid hormone promotes expression of peroxisome proliferator-activated receptor-gamma coactiv
243 n of the mitochondrial biogenesis regulators peroxisome proliferator-activated receptor-gamma coactiv
244 ctivated receptor-gamma coactivator 1-alpha, peroxisome proliferator-activated receptor-gamma coactiv
245 lso show increased expression of PGC-1alpha (peroxisome proliferator-activated receptor-gamma coactiv
246  dismutase 2 (SOD2), and increased levels of peroxisome proliferator-activated receptor-gamma coactiv
247 a Silent information regulator 1 (SIRT1) and peroxisome proliferator-activated receptor-gamma coactiv
248  that 3-oxo-C12-HSL attenuates expression of peroxisome proliferator-activated receptor-gamma coactiv
249 EFs show increased expression of PGC-1alpha (peroxisome proliferator-activated receptor-gamma coactiv
250 (-/-) OPCs with cholesterol or activation of peroxisome proliferator-activated receptor-gamma with pi
251 ease of a transferable factor able to induce peroxisome proliferator-activated receptor-gamma-mediate
252 roxynonenal) released from the heart trigger peroxisome proliferator-activated receptor-gamma-mediate
253 al LPS exposure led to pre-existing elevated peroxisome proliferators-activated receptor-gamma co-act
254 Tfe3, control the regulator of adipogenesis, peroxisome proliferator-activated receptor gamma2 (Pparg
255 protein-1 (MURF1)-mediated ubiquitylation of peroxisome proliferator-activated receptor gamma2 (PPARg
256 tein expressions of extracellular matrix and peroxisome proliferator-activated receptor pathways in s
257 essed the hypothesis that variability in the Peroxisome Proliferator Activated Receptor (PPAR) pathwa
258       Here we investigated the impact of the peroxisome proliferator-activated receptor (PPAR) agonis
259    We hypothesized that bezafibrate, a broad peroxisome proliferator-activated receptor (PPAR) agonis
260 noma cells and is upregulated by agonists of peroxisome proliferator-activated receptor (PPAR) alpha
261                  We investigated the role of peroxisome proliferator-activated receptor (PPAR) beta/d
262        Here we identify the nuclear receptor peroxisome proliferator-activated receptor (PPAR) delta
263 ption factors farnesoid X receptor (FXR) and peroxisome proliferator-activated receptor (PPAR) delta
264                                          The peroxisome proliferator-activated receptor (PPAR) family
265 bound by the adipocytic transcription factor peroxisome proliferator-activated receptor (PPAR) gamma,
266 of SOD2 (superoxide dismutase 2), PGC1alpha [peroxisome proliferator-activated receptor (PPAR) gamma-
267 s, we identify circulating factors involving peroxisome proliferator-activated receptor (PPAR) pathwa
268 d mothers against decapentaplegic homologs), peroxisome proliferator-activated receptor (PPAR), and P
269 a models, we report that CD8(+) TILs enhance peroxisome proliferator-activated receptor (PPAR)-alpha
270                                Activation of peroxisome proliferator-activated receptor (PPAR)-alpha
271 etion from hepatocytes in vivo downregulated peroxisome proliferator-activated receptor (PPAR)-alpha,
272 nt receptor potential vanilloid (TRPV)-1 and peroxisome proliferator-activated receptor (PPAR)-alpha.
273                                              Peroxisome proliferator-activated receptor (PPAR)-delta
274 ipogenesis (+30% Oil Red O stain [ORO], +50% peroxisome proliferator-activated receptor (PPAR)-gamma
275                                              Peroxisome proliferator-activated receptor (PPAR)-gamma
276 chanistic target of rapamycin (mTOR) and the peroxisome proliferator-activated receptor (PPAR)-gamma
277  latter case, this involves up-regulation of peroxisome proliferator-activated receptor (PPAR)alpha e
278 , dipeptidyl peptidase 4 (DPP-4) inhibitors, peroxisome proliferator-activated receptor (PPAR-gamma/a
279 of genes related to fatty acid synthesis and peroxisome proliferator-activated receptor (PPARalpha) s
280 s complex failed to alter, while blockade of peroxisome proliferator-activated receptors (PPARalpha,
281  into lipid-laden adipocytes by upregulating peroxisome proliferator-activated receptor (PPARgamma) a
282 o the arylhydrocarbon receptor (AhR) and the peroxisome proliferator-activated receptor (PPARgamma);
283                                              Peroxisome proliferator-activated receptors (PPARs) are
284                                              Peroxisome proliferator-activated receptors (PPARs) are
285 he role of PPARgamma SIGNIFICANCE STATEMENT: Peroxisome proliferator-activated receptors (PPARs) are
286          Over the course of the past decade, peroxisome proliferator-activated receptors (PPARs) have
287 tor families retinoid X receptors (RXRs) and peroxisome proliferator-activated receptors (PPARs) hold
288                                              Peroxisome proliferator-activated receptors (PPARs) regu
289                                              Peroxisome proliferator-activated receptors (PPARs) regu
290        Bezafibrate (BEZ), a pan activator of peroxisome proliferator-activated receptors (PPARs), has
291 iptionally repress FAO genes, antagonists of peroxisome proliferator-activated receptors (PPARs), par
292  NRs for treating metabolic diseases are the peroxisome proliferator-activated receptors (PPARs), PPA
293                                An isoform of peroxisome proliferator-activated receptors (PPARs), PPA
294                Given that some PFAS activate peroxisome proliferator-activated receptors (PPARs), we
295 th 14 other nuclear receptors, including the peroxisome proliferator-activated receptors (PPARs).
296  of inflammatory mediators and repression of peroxisome proliferator-activated receptor signaling and
297 n metabolic pathways, some linked to altered peroxisome proliferator-activated receptor signaling, mu
298 the first week due to failure to undergo the peroxisome proliferator-activated receptor signaling-dep
299  KLF5 (Kruppel-like factor-5) and PPARalpha (peroxisome proliferator-activated receptor) that regulat
300  (NFAT) and potentiated the transcription of peroxisome proliferator-activated receptor-y coactivator

 
Page Top